Shahar Keinan, CEO of Polaris Quantum Biotech, is a 2024 Speaker for the IQT Quantum + AI Conference
At the upcoming IQT Quantum + AI conference, the spotlight will shine on Dr. Shahar Keinan, CEO and co-founder of POLARIS Quantum Biotech, who stands at the intersection of quantum computing and biotechnology. Dr. Keinan, with her profound expertise in computational and theoretical chemistry, brings over two decades of pioneering work in the realm of in-silico drug design and discovery. Her academic journey, which began with a Ph.D. from The Hebrew University of Jerusalem, further expanded through postdoctoral positions at Northwestern University and Duke University, setting the stage for her remarkable contributions to the field.
Dr. Keinan’s professional trajectory includes her role as the Chief Scientific Officer at Cloud Pharmaceuticals, where she was pivotal in the development and advancement of the Quantum Molecular Design process. This groundbreaking work, initiated at Duke University, represents a leap forward in the utilization of inverse design algorithms. Such algorithms are crucial for optimizing electro-optical materials and small molecule drugs, offering a new paradigm in drug discovery and material science.
The integration of quantum computing with artificial intelligence, as envisioned and implemented by Dr. Keinan at POLARIS Quantum Biotech, promises to revolutionize how we approach and solve complex problems in drug discovery. By leveraging quantum computing’s unparalleled computational capabilities, POLARIS aims to significantly accelerate the discovery process, making it more efficient and cost-effective.
Attendees of the Quantum + AI conference can expect Dr. Keinan to share valuable insights into the fusion of quantum computing and AI in biotech, particularly how this synergy is poised to facilitate breakthroughs in drug design and discovery. Her session will not only highlight the innovative strategies employed by POLARIS Quantum Biotech but also underscore the transformative potential of quantum technologies in tackling some of the most challenging issues in healthcare and medicine.
QUANTUM + AI conference-New York City-October 29-30, 2024
The inaugural IQT QUANTUM + AI conference promises to be a pioneering event, uniting Quantum Computing and Artificial Intelligence (AI) leaders to explore the synergistic potential of merging these two revolutionary technologies. This event aims to address the current challenges and vast opportunities at the intersection of quantum computing and AI, promising to enhance AI’s capabilities through quantum-powered algorithms, machine learning techniques, and data processing methods beyond the reach of classical computing. By enabling faster and more efficient processing of large, complex datasets, quantum computing is poised to supercharge AI applications across various sectors, including pharma, finance, and defense, heralding a new era of accelerated machine learning, improved predictions, and optimized processes. Despite the technical hurdles, such as the need for better error correction and fault tolerance in quantum computing and the development of quantum-optimized software for AI decision-making, the conference underscores the transformative impact of Quantum AI on advancing technological frontiers across numerous industries.
